EPRX

Eupraxia Pharmaceuticals Inc.

CA Healthcare Biotechnology

Latest week
10 Jul 2026
Close
9.460000
Fair value
6.492436
Next-week expectancy
Undecided 52.53%
Sharemaestro

EPRX Chart Pack

Eupraxia Pharmaceuticals Inc.

Exchange
TOR
Latest week
10 Jul 2026
Close
9.460000
Fair value
6.492436
Next-week expectancy
Undecided 52.53%
Generated
17 Jul 2026 14:30
Sector
Healthcare
Industry
Biotechnology

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, EPRX fell 4.25%, moving from 9.88 to 9.46. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -7.59 and has softened across the 12-week window. Market Dynamics is -0.23 on the latest week. Next-week expectancy is undecided at 52.53% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
9.46
12-Week Change
-4.25%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.53%
Signal Weeks
2 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-7.59
Market Dynamics
-0.23

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
9.46
12-Week Change
-4.25%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.53%
Signal Weeks
2 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-7.59
Market Dynamics
-0.23

Over the latest 12 completed weeks ending 2026-07-10, EPRX fell 4.25%, moving from 9.88 to 9.46. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -7.59 and has softened across the 12-week window. Market Dynamics is -0.23 on the latest week. Next-week expectancy is undecided at 52.53% based on similar historical setup states.

Industry Peers

Canada equities in Biotechnology

Stock Exchange Week Open High Low Close Change
MSCL Satellos Bioscience Inc. TOR 10 Jul 2026 10.95 14.15 10.86 13.53 23.56%
BCT BriaCell Therapeutics Corp. TOR 10 Jul 2026 4.82 5.64 4.82 5.58 15.77%
MBX Microbix Biosystems Inc. TOR 10 Jul 2026 0.30 0.32 0.30 0.32 6.67%
APS Aptose Biosciences Inc. TOR 3 Jul 2026 2.25 2.41 2.13 2.40 6.67%
HBP Helix BioPharma Corp. TOR 10 Jul 2026 1.43 1.45 1.25 1.44 0.70%
APLI Appili Therapeutics Inc. TOR 10 Jul 2026 0.02 0.02 0.01 0.02 0.00%
RVX Resverlogix Corp. TOR 10 Jul 2026 0.10 0.10 0.09 0.10 0.00%
FRX Fennec Pharmaceuticals Inc. TOR 10 Jul 2026 15.32 15.32 14.40 14.50 -5.35%
SVA Sernova Biotherapeutics Inc TOR 10 Jul 2026 0.14 0.14 0.13 0.13 -7.14%
MDNA Medicenna Therapeutics Corp. TOR 10 Jul 2026 0.40 0.41 0.36 0.37 -7.50%
CSCI COSCIENS Biopharma Inc. TOR 10 Jul 2026 9.18 14.80 8.10 8.10 -11.76%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.